Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
REGENXBIO | RGNX | Dec 27, 2024 | 7.41 | -5.85 |
Regional Health Properties | RHE | Dec 27, 2024 | 1.55 | +0.65 |
Regional Health Properties A Pref | RHE-A | Dec 27, 2024 | 0.29 | -6.60 |
Regional Management | RM | Dec 27, 2024 | 33.72 | -2.63 |
Regions Financial | RF | Dec 27, 2024 | 23.74 | -1.04 |
Regions Financial B Pref | RF-B | Dec 27, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Dec 27, 2024 | 23.85 | +0.08 |
Regions Financial E Pref | RF-E | Dec 27, 2024 | 17.46 | -1.30 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Dec 27, 2024 | 25.79 | +0.39 |
Regis | RGS | Dec 27, 2024 | 25.51 | -1.28 |
Regulus Therapeutics | RGLS | Dec 27, 2024 | 1.54 | -3.75 |
Reinsurance Group of America | RGA | Dec 27, 2024 | 211.41 | -0.88 |
REIT Index ETF Vanguard | VNQ | Dec 27, 2024 | 88.75 | -1.00 |
Reitar Logtech | RITR | Dec 27, 2024 | 4.20 | +1.20 |
Rekor Systems | REKR | Dec 27, 2024 | 1.30 | +27.45 |
Relay Therapeutics | RLAY | Dec 27, 2024 | 4.36 | -2.02 |
Reliance | RS | Dec 27, 2024 | 269.73 | -0.58 |
Reliance Global | RELI | Dec 27, 2024 | 2.38 | -10.53 |
Relmada Therapeutics | RLMD | Dec 27, 2024 | 0.38 | +5.74 |
RELX ADR | RELX | Dec 27, 2024 | 45.58 | -0.61 |
Remitly Global | RELY | Dec 27, 2024 | 22.80 | -1.17 |
Renaissance Ipo ETF | IPO | Dec 27, 2024 | 44.81 | -1.52 |
RenaissanceRe | RNR | Dec 27, 2024 | 250.63 | -0.13 |
RenaissanceRe G Pref | RNR-G | Dec 27, 2024 | 16.54 | -1.43 |
RenaissanceRe Holding F Pref | RNR-F | Dec 27, 2024 | 22.49 | -1.40 |
Renalytix ADR | RNLX | Dec 27, 2024 | 0.20 | 0.00 |
Renasant | RNST | Dec 27, 2024 | 35.79 | -0.50 |
ReNew Energy Global A Shares | RNW | Dec 27, 2024 | 6.82 | +0.89 |
Renn Fund | RCG | Dec 27, 2024 | 2.41 | -2.03 |
Renovaro Biosciences | RENB | Dec 27, 2024 | 0.92 | +1.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.